首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1608845

大腸直腸癌治療市場：依治療類型、給藥途徑、通路及地區分類

Colorectal Cancer Therapeutics Market, By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, and Others), By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年11月04日 | 出版商:

Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

大腸直腸癌治療市場預計到2024年將達到89.8億美元，預計到2031年將達到121億美元，2024年至2031年的複合年成長率為4.3%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	89.8億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	4.30%	2031 年金額預測	121億美元

圖：2024 年按地區分類的結直腸癌治療藥物市場佔有率（%）

大腸直腸癌是世界上最常見的癌症之一，也是癌症相關死亡的主要原因。根據世界衛生組織（WHO）統計，2020年全球將有超過190萬人新診斷出大腸癌，每年將有超過90萬人死於大腸癌。大腸直腸癌盛行率的增加和有限的治療選擇增加了對有效治療藥物的需求。多家生物製藥公司致力於開發新型標靶治療方法，例如標靶單株抗體、蛋白激酶抑制劑和免疫查核點抑制劑，以治療大腸直腸癌。

市場動態

全球大腸直腸癌治療市場的成長是由全球大腸癌盛行率上升所推動的。據美國癌症協會稱，2020年美國每年將診斷出超過15萬例大腸癌新病例。此外，政府和癌症組織擴大舉措來提高人們對大腸癌早期檢測和治療的認知，這可能會推動市場成長。然而，新型標靶治療的高成本可能會阻礙其廣泛使用。持續研究和開發新一代生物標記引導的個人化療法可能會創造利潤豐厚的成長機會。

本研究的主要特點

該報告對全球結直腸癌治療藥物市場進行了詳細分析，並列出了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球結直腸癌治療市場的主要企業進行了分析。

本研究涵蓋的主要企業包括賽諾菲、百時美施貴寶公司、拜耳公司、小野製藥有限公司、ALX Oncology Inc.、第一三共有限公司、輝瑞公司、Exelixis, Inc.、SOTIO Biotech AG 、AB Science、BioNTech SE、Effector Therapeutics, Inc. 和Treos Bio Limited。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球結直腸癌治療藥物市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。

透過用於分析全球大腸直腸癌治療藥物市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	8.98 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	4.30%	2031 Value Projection:	12.10 Bn

Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer-related mortality. According to World Health Organization (WHO), in 2020, over 1.9 million new cases of colorectal cancer are diagnosed globally and more than 0.9 million deaths due to colorectal cancer occur annually. Rising prevalence of colorectal cancer and limited treatment options have boosted demand for effective therapeutics. Several biopharma companies are focusing on developing novel targeted therapeutic approaches such as targeted monoclonal antibodies, protein kinase inhibitors, and immune checkpoint inhibitors to treat colorectal cancer.

Market Dynamics

Global colorectal cancer therapeutics market growth is driven by rising prevalence of colorectal cancer worldwide. In 2020, according to the American Cancer Society, over 150,000 new cases of colorectal cancer are diagnosed in the U.S. every year. Moreover, increasing initiatives by governments and cancer organizations to spread awareness about early detection and treatment of colorectal cancer can drive the market growth. However, high costs associated with novel targeted therapies can hamper its widespread adoption. Ongoing research & development for developing new generation biomarker-guided personalized therapies can create lucrative growth opportunities.

Key features of the study

This report provides in-depth analysis of the global colorectal cancer therapeutics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global colorectal cancer therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Sanofi, Bristol-Myers Squibb Company, Bayer AG, Ono Pharmaceutical Co. Ltd, ALX Oncology Inc., Daiichi Sankyo Company, Limited, Pfizer Inc., Exelixis, Inc., SOTIO Biotech AG, AB Science, BioNTech SE, Effector Therapeutics, Inc., and Treos Bio Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global colorectal cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colorectal cancer therapeutics market

Market Segmentation

Therapy Type Insights (Revenue, USD, 2019 - 2031)
- Chemotherapy
- Alkylating Agents
- Antimetabolites
- Others
- Immunotherapy
- Immune Checkpoint Inhibitors
- Oncolytic Virus Therapy
- Others
- Targeted Therapy
- Monoclonal antibodies
- Small molecule inhibitors
- Others
Route of Administration Insights (Revenue, USD, 2019 - 2031)
- Oral
- Intravenous
- Intramuscular
- Subcutaneous
- Others
Distribution Channel Insights
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Sanofi
- Bristol-Myers Squibb Company
- Bayer AG
- Ono Pharmaceutical Co. Ltd
- ALX Oncology Inc.
- Daiichi Sankyo Company, Limited
- Pfizer Inc.
- Exelixis, Inc.
- SOTIO Biotech AG
- AB Science
- BioNTech SE
- Effector Therapeutics, Inc.
- Treos Bio Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Colorectal Cancer Therapeutics Market, By Therapy Type
- Colorectal Cancer Therapeutics Market, By Route of Administration
- Colorectal Cancer Therapeutics Market, By Distribution Channel
- Colorectal Cancer Therapeutics Market, Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology
Pipeline Analysis

4. Colorectal Cancer Therapeutics Market, By Therapy Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Alkylating Agents
- Antimetabolites
- Others
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Immune Checkpoint Inhibitors
- Oncolytic Virus Therapy
- Others
Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Monoclonal antibodies
- Small molecule inhibitors
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Colorectal Cancer Therapeutics Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Colorectal Cancer Therapeutics Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Colorectal Cancer Therapeutics Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ono Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ALX Oncology Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Daiichi Sankyo Company, Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exelixis, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SOTIO Biotech AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AB Science
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioNTech SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Effector Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Treos Bio Limited